Shareholder plans sale of 544 shares in company (NASDAQ: DAVE)

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sale of 544 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or around 02/02/2026 on the NASDAQ market. The filing lists an aggregate market value of 89047.36 for these shares and states that there were 12,190,000 shares outstanding at the time of the notice. The shares to be sold were acquired as restricted stock units from the issuer on 01/31/2025, with the same date shown as the date of payment. The person for whose account the securities are to be sold represents that they do not know of any undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	544	89047.36	12190000	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2025	Restricted Stock Units	Issuer			544	01/31/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for DAVE indicate?

It indicates a planned sale of 544 common shares by a shareholder. The shares, valued in total at 89047.36, are expected to be sold on NASDAQ through Morgan Stanley Smith Barney, subject to Rule 144 conditions and representations about public disclosure.

How many DAVE shares are planned to be sold and through which broker?

The filing shows a plan to sell 544 common shares of the issuer. The transaction is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, using the NASDAQ exchange.

What is the aggregate market value of the DAVE shares in this Form 144?

The aggregate market value of the shares covered by this notice is listed as 89047.36. This figure relates specifically to the 544 common shares proposed for sale under Rule 144, as disclosed in the securities information section of the filing.

When were the DAVE shares to be sold originally acquired?

The shares were acquired on 01/31/2025 as restricted stock units from the issuer. The filing also records 01/31/2025 as the date of payment, with the nature of payment marked as N/A, indicating a non-cash RSU acquisition structure.

What is the approximate planned sale date for these DAVE shares?

The approximate date of sale for the 544 common shares is listed as 02/02/2026. This date reflects when the shareholder expects to execute sales on the NASDAQ exchange, subject to market conditions and Rule 144 requirements.

How many DAVE shares were outstanding at the time of this notice?

The filing reports that 12,190,000 shares of the issuer’s common stock were outstanding. This number provides context for the planned sale of 544 shares, showing the relative size of the proposed transaction versus total outstanding shares.